Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration to manufacture and market Azithromycin Tablets USP, 500 mg.
Shilpa Medicare Ltd has received U.S Food and Drug Administration final approval for its ANDA, Apremilast Tablets, 10 mg, 20 mg, and 30 mg for the treatment of adult patients with active psoriatic arthritis. The product is executed from a contract manufac
Zydus Lifesciences Ltd has received final approval from the USFDA to manufacture and market Carbidopa and Levodopa Tablets USP, 10 mg/100 mg, 25 mg/100 mg, and 25 mg/250 mg.
Alembic Pharmaceuticals Limited today announced that it has received final approval from the US Food & Drug Administration for its Abbreviated New Drug Application Brimonidine Tartrate Ophthalmic Solution, 0.15%.
Zydus Lifesciences Ltd has received final approval for Levothyroxine Sodium for Injection, 100 mcg/vial, 200 mcg/vial, and 500 mcg/vial from the United States Food and Drug Administration.